The Use of Intranasal Ketoralac for Pain Management (Sprix)
Status:
Terminated
Trial end date:
2014-06-01
Target enrollment:
Participant gender:
Summary
Despite an overall reduction in the perioperative complication rate, post operative pain
management after ureteroscopic removal of stones (URS) remains a major factor delaying
discharge of patients. The investigators hypothesize that perioperative usage of intranasal
ketorolac will provide a reduction in post operative opioid requirements, better post
operative pain control, higher anesthesia satisfaction and faster recovery.